AstraZeneca Sues Teva Over Seroquel Patent Challenge
AstraZeneca has sued Israeli drug maker Teva Pharmaceuticals in the U.S. District Court for the District of New Jersey, alleging that Teva’s attempts to market a generic version of popular antipsychotic drug Seroquel amount to infringement of AstraZeneca’s patents for the drug, which are set to expire in 2011.
In September, Teva filed an...
Already a subscriber? Click here to login